IRVINE, Calif., Jan. 4 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. today announced that it will present at the JPMorgan Healthcare Conference at 12:00 p.m. Pacific Time on Thursday, January 12, 2006 at The Westin St. Francis in San Francisco, CA. ISTA’s Chief Executive Officer, Vicente Anido, Jr., Ph.D. will provide an update on the Company’s commercial and clinical progress.
To access the live audio broadcast or the subsequent archived recording log on to http://www.istavision.com. Please connect to the website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.
ABOUT ISTA
ISTA is a specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products. ISTA’s products and product candidates seek to address serious diseases and conditions of the eye such as dry eye, vitreous hemorrhage, diabetic retinopathy, hyphema, glaucoma and inflammation. Building on this pipeline, ISTA’s goal is to continue its growth as a specialty pharmaceutical company by acquiring complementary products, either already marketed or in late-stage development. For additional information regarding ISTA, please visit ISTA Pharmaceuticals’ Website at http://www.istavision.com.
For more Information Contact: Vince Anido, ISTA Pharmaceuticals 949-788-5311 vanido@istavision.com Lauren Silvernail, ISTA Pharmaceuticals 949-788-5302 lsilvernail@istavision.com Burns McClellan Justin Jackson (Media) jjackson@burnsmc.com Lisa Burns or Laura Siino (Investors) 212-213-0006 lsiino@burnsmc.com
ISTA Pharmaceuticals, Inc.
CONTACT: Vince Anido, +1-949-788-5311, vanido@istavision.com, or LaurenSilvernail, +1-949-788-5302, lsilvernail@istavision.com, both of ISTAPharmaceuticals, Inc.; or Media - Justin Jackson, jjackson@burnsmc.com, orInvestors - Lisa Burns or Laura Siino, +1-212-213-0006, lsiino@burnsmc.com,all of Burns McClellan for ISTA Pharmaceuticals, Inc.
Web site: http://www.istavision.com/
